40 articles
Robbie G. Majzner
Robbie G. Majzner is a physician-scientist in pediatric oncology and cancer immunotherapy who directs the Pediatric and Young Adult Cancer Cell Therapy Program at Dana-Farber/Boston Children's Hospital.
Sattva S. Neelapu
Sattva S. Neelapu is a physician-scientist at MD Anderson Cancer Center in Houston who develops CAR T-cell immunotherapies for B-cell malignancies and led the pivotal ZUMA-1 trial.
Sidi Chen
Sidi Chen is a geneticist and Associate Professor at Yale School of Medicine known for genome-wide CRISPR screens in living animals that uncover cancer immunotherapy targets.
Sjoerd H. van der Burg
Sjoerd H. van der Burg is a Dutch immunologist, full professor of immunotherapy of solid tumors at Leiden University Medical Center since 2010, studying T cells and cancer.
Stanley Riddell
Stanley R. Riddell is a tumor immunologist and physician-scientist at Fred Hutch Cancer Center who pioneered adoptive T cell therapy for cancer and co-founded Juno Therapeutics in 2013.
Stephan A. Grupp
Stephan A. Grupp is a pediatric oncologist and cell therapy researcher at Children's Hospital of Philadelphia whose trials led to Kymriah, the first CAR T-cell therapy approved in the United States.
Steven Rosenberg
Steven Rosenberg is an American surgeon and cancer researcher who has led the National Cancer Institute's Surgery Branch since 1974, pioneering IL-2, TIL, and CAR T-cell immunotherapies for cancer.
Taha Merghoub
Taha Merghoub is an Algerian-born cancer immunotherapy researcher, Deputy Director of the Meyer Cancer Center at Weill Cornell Medicine since 2022 after a career at Memorial Sloan Kettering.
Vinod P. Balachandran
Vinod P. Balachandran is a surgeon-scientist and hepatopancreatobiliary surgeon at Memorial Sloan Kettering Cancer Center in New York, known for leading the first clinical trial of a personalized mRNA neoantigen vaccine against pancreatic cancer.
William Coley
William Bradley Coley (1862–1936) was a New York bone surgeon who developed Coley's toxins, heat-killed bacteria injected into cancer patients, and is often called the Father of Immunotherapy.